U.S. Clears Seroquel for Bipolar Depression
Medscape News - LONDON (Reuters) Oct 20 - AstraZeneca Plc said on Friday it had won U.S. approval for Seroquel (quetiapine) to be sold as treatment for bipolar depression. The antipsychotic drug had already been cleared by the Food and Drug Administration as a
Source: www.medscape.com
Click here for more information about manic depression manic depression
<< Home